Procainamide TMS
Compound with spectra: 1 MS (GC)
| SpectraBase Compound ID | EfjCsequdlm |
|---|---|
| InChI | InChI=1S/C16H29N3OSi/c1-6-19(7-2)13-12-17-16(20)14-8-10-15(11-9-14)18-21(3,4)5/h8-11,18H,6-7,12-13H2,1-5H3,(H,17,20) |
| InChIKey | RPRXYAOTICZXNC-UHFFFAOYSA-N |
| Mol Weight | 307.51 g/mol |
| Molecular Formula | C16H29N3OSi |
| Exact Mass | 307.207989 g/mol |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
- N-(2-(diethylamino)ethyl)-4-((trimethylsilyl)amino)benzamide
N-Acetylprocainamide
N-[2-(DIETHYLAMINO)ETHYL]-p-NITROBENZAMIDE
4-Methoxy-N-(2-piperidin-1-yl-ethyl)-benzamide
4-Methoxy-N-(2-morpholin-4-yl-ethyl)-benzamide
MEOP-M (N,N-bisdealkyl-) AC
Benzamide, 4-[2-phenyldiazenyl]-N-propyl-
N-butyl-p-phenylazobenzamide
4-Aminobenzoic acid 2TMS
2-(4-Thioureidobenzamido)acetic acid
3-Bromo-N-(2-diethylaminoethyl)benzamide
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.